A Study on the Efficacy and Safety of Venetoclax Combined With HAA Regimen in Newly Diagnosed Young AML.
Clinical trial NCT05893472 · UNKNOWN
Trial details
- NCT number
- NCT05893472
- Sponsor
- ZePing Zhou
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-01
- Primary completion
- 2024-04-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.